Open AccessClinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Hyderabad cohort of the A1chieve study
Author(s) -
Santosh Ramakrishnan,
Ravi Mehrotra,
Nadiminty Ganapathi Sastry
Publication year - 2013
Publication title -
indian journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.456
H-Index - 28
eISSN - 2230-9500
pISSN - 2230-8210
DOI - 10.4103/2230-8210.122130
Subject(s) - insulin aspart , insulin detemir , medicine , insulin , basal insulin , endocrinology , diabetes mellitus , type 2 diabetes , basal (medicine) , cohort , hypoglycemia
The A1chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care across four continents.